First multivisceral transplantation in Mitchell-Riley/Martinez-Frias syndrome

Karla Estefanía-Fernández1, Ane Andrés1, Alida Alcolea2

  • 1Department of Pediatric Surgery, La Paz University Hospital, Madrid, Spain.

Abstract

Insights

Multivisceral transplantation (MVT) offers a promising survival option for rare multisystemic disorders like MRS/MFS. This case demonstrates long-term success in a patient with severe gastrointestinal and pancreatic conditions.

Area of Science:

  • Genetics
  • Pediatric Surgery
  • Gastroenterology

Background:

  • MRS/MFS is a rare, severe multisystem disorder with high mortality.
  • Gastrointestinal, pancreatic, and hepatobiliary complications often resist conventional treatments.

Observation:

  • A Romani newborn with MRS/MFS presented with duodenal atresia, hypoplastic pancreas, gallbladder agenesis, and neonatal diabetes.
  • Genetic analysis revealed a homozygous RFX6 variant, confirming MRS/MFS.
  • The patient experienced intractable secretory diarrhea and severe intestinal failure.

Findings:

  • The patient underwent multivisceral transplantation (MVT) at age 2, involving stomach, duodenum, small intestine, colon, liver, and pancreas.
  • Histology showed gastric heterotopia in the small bowel.
  • Over 10 years post-transplant, the patient achieved normal gastrointestinal, hepatic, and pancreatic function, representing one of the longest survivals reported.

Implications:

  • Multivisceral transplantation (MVT) may be a viable therapeutic strategy for select MRS/MFS cases.
  • This case highlights the potential of MVT to significantly improve long-term outcomes in patients with complex congenital disorders.